Rescinnamine: Difference between revisions
Jump to navigation
Jump to search
m Protected "Rescinnamine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
Line 21: | Line 21: | ||
{{CMG}} | {{CMG}} | ||
Revision as of 15:39, 20 August 2012
Clinical data | |
---|---|
Routes of administration | oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C35H42N2O9 |
Molar mass | 634.716 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug. It is an alkaloid obtained from Rauwolfia serpentina and other species of Rauwolfia.
Brand names
Moderil®, Cinnasil®, Anaprel®
Categories:
- Pages with script errors
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- ACE inhibitors
- Drugs